Pimitespib (TAS-116) is an oral bioavailable, ATP-competitive, highly specific HSP90alpha/HSP90beta inhibitor (Kis of 34.7 nM and 21.3 nM, respectively) without inhibiting other HSP90 family proteins such as GRP94[1]. Pimitespib demonstrates less ocular toxicity[2].
Molecular Weight:
454.53
Purity:
99.15
CAS Number:
[1260533-36-5]
Formula:
C25H26N8O
Target:
HSP
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted